Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 HER2-positive Breast Cancer 6 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Rare Tumor 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 HER2-positive Advanced Breast Cancer 1 HER2-expressing Advanced Solid Tumors 1 HER2 Positive Breast Cancer 1 HER2 Insertion Mutation Positive Advanced NSCLC 1 Esophageal Squamous Cell Carcinoma 1 Breast Neoplasm Female 1 Breast Cancer Metastatic 1 Breast Cancer Invasive 1 Breast Cancer Female 1 Advanced Breast Cancer 1

Interventions

pyrotinib 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Breast Cancer Invasive × pyrotinib × Clear all

NCT05910398 2025-11-18

CORINNE-PI

RenJi Hospital

Phase 3 Recruiting

Breast Cancer Invasive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡